eRAM
encyclopedia of Rare Disease Annotation for Precision Medicine
| Disease | oral leukoplakia |
| Comorbidity | C0026640|oral cancer |
| Sentences | 4 |
| PubMedID- 21697275 | Ezh2 promotes malignant phenotypes and is a predictor of oral cancer development in patients with oral leukoplakia. |
| PubMedID- 23473850 | Objectives: recent studies have identified podoplanin, a mucin-type transmembrane glycoprotein, as a biomarker for oral cancer risk in patients with oral leukoplakia (opl). |
| PubMedID- 23229239 | These limitations must be taken into account and studies involving larger patient series and regular follow-up over longer periods of time are needed in order to derive more reliable information on the role of invasive surgical resection in the prevention of oral cancer in patients with oral leukoplakia. |
| PubMedID- 25552924 | Studies have revealed that bmi-1 expression is associated with the development of oral cancer in patients with oral leukoplakia (lp) 14, oral erythroplakia 11, and oral lichen planus 15. in clinical specimens of hnscc, many researchers have found that the overexpression of bmi-1 correlates with poor overall survival 13,16,31. similarly, we also found that the expression of bmi1 was higher in tscc and correlated with a poor overall survival and was also associated with lymph node metastasis and clinical stage. |
Page: 1